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Marfan syndrome, affecting approximately one out of every 5,000 people, is 
characterized by abnormal bone growth, ectopia lentis, and often-fatal aortic dilation and 
dissection. The root cause is a faulty extracellular matrix protein, fibrillin-1, which 
associates with elastin in many tissues. Common carotids from wild-type controls and 
mice heterozygous for the mgR mutation, the most commonly used mouse model of 
Marfan syndrome, were studied in a biaxial testing device. Mechanical data in the form 
of pressure-diameter and force-stretch tests in both the active and passive states were 
collected, as well data on the functional responses to phenylephrine, carbamylcholine 
chloride, and sodium nitroprusside. Although little significant difference was found 
between the heterozygous and wild-type groups in general, the in vivo stretch for both 
groups was significantly different from previously studied mouse vessels. Although the 
two groups do not exhibit significant differences, this study comprises a control group 
for future work with mice homozygous for mgR, which do exhibit Marfan-like 
symptoms. As treatment of Marfan syndrome improves, more Marfan patients will 
survive and age, increasing the likelihood that they will develop many of the vascular 
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complications affecting the normal population, including hypertension and 
atherosclerosis. Therefore, it is imperative to gather biomechanical data from the Marfan 
vasculature so that clinicians may predict the effects of vascular complications in Marfan 
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Marfan syndrome, affecting approximately one out of every 5,000 people, is 
characterized by abnormal bone growth, ectopia lentis, and aortic dilation and dissection. 
If left untreated, Marfan patients often die prematurely due to aortic dissection, but 
improved treatment dramatically decreases the death rate to near normal (Pyeritz, 2000). 
As Marfan patients survive and age, they will likely develop many of the vascular 
complications affecting the normal population, including hypertension and 
atherosclerosis. Therefore, it is imperative to gather biomechanical data from the Marfan 
vasculature so that clinicians may predict the effects of vascular complications in Marfan 
patients and develop appropriate methods of treatment. Although the aortas in both 
human patients and animal models of Marfan syndrome are stiffer than controls 
(Groenink et al., 1998; Jeremy et al., 1994; Marque et al., 2001), little research has been 
done on other arteries. This thesis compares the mechanical response of common carotid 
arteries from wild-type and heterozygous mgR mice, the most commonly used mouse 
model of Marfan syndrome. The following introductory sections briefly discuss how 
Marfan syndrome presents in human patients, how the extracellular matrix protein 
fibrillin-1 relates to Marfan syndrome, and what recently developed mouse models of the 
disease are currently used in the studies of the syndrome. Finally, there is a brief review 




This thesis follows the style and format of the Journal of Biomechanics. 
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Symptoms and Prognosis of Marfan Syndrome 
Identified by Antonine-Bernard Marfan in 1896, Marfan syndrome is an inherited 
disease affecting numerous systems in the body. The disease results from a variety of 
mutations in the gene coding for the elastin-associated matrix protein fibrillin-1. 
Generally, the systems most obviously affected include the eyes, skeleton, and 
vasculature, although the skin, lungs, heart, muscles, and adipose tissue may be 
involved. The disease spans a wide variety of phenotypes, ranging from mild aortic 
dilation coupled with displaced lenses and slight skeletal abnormalities to death in 
infancy due to congestive heart failure (Pyeritz, 2000).  
Marfan patients are prone to numerous skeletal malformations, including 
scoliosis, long bone overgrowth, arachnodactyly, and rib deformations (Pyeritz, 2000). 
These features were long thought to arise from decreased tension on the bones by 
weakened microfibrils (Keene et al., 1997), but recent studies (Neptune et al., 2003; 
Habashi et al., 2006) suggest that microfibrils play a role in properly presenting growth 
factors such as transforming growth factor β (TGFβ) to cells. TGFβ negatively affects 
growth and proliferation of many cells (Öklü and Hesketh, 2000), and if the mutant 
microfibrils fail to properly modulate TGFβ, the cartilage cells may proliferate 
inappropriately, laying down a scaffold for improper bone growth (Ramirez and Rifkin, 
2003). Severe scoliosis is generally treated with bracing or surgical stabilization, while 
extreme sternum depressions may be temporarily braced and repaired after cessation of 
rib growth (Pyeritz, 2000). 
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The zonules that support the lens in the eye consist almost entirely of microfibrils 
(Davis et al., 2002). Marfan patients often, but not always, exhibit extreme myopia 
caused by elongated globes and displacement of the lens (ectopia lentis) as the result of 
stretched or broken zonules (Nelson and Maumenee, 1982). Sachdev et al. (2003, 2004) 
postulate that some fibrillin-1 mutations may render the microfibrils more susceptible to 
degradation by matrix metalloproteinases (MMPs) and ultraviolet light, leading to lens 
dislocation. If the lens displaces completely or the lens bisects the pupil, the lens is 
generally removed and vision is corrected with an interocular lens or with external 
aphakic optics (Wu-Chen et al., 2005). 
While the symptoms described above may decrease a patient's quality of life, 
they are seldom fatal. In contrast, vascular complications of Marfan syndrome such as 
aortic dilation and dissection may result in early death if left untreated (Pyeritz, 2000). 
Bunton et al. (2001), in a review of arterial specimens from seven Marfan patients, noted 
unusual elastic fiber calcification, intimal hyperplasia, and collagen deposition. 
Although such findings are common in the elderly segment of the normal population, the 
average age at death of the Marfan patients studied was 33 years. Because aortic dilation 
may begin before birth, and progresses unpredictably, many patients are treated with β-
adrenegic blocking drugs to reduce blood pressure, thus limiting the distending forces on 
the aorta. Doctors often advise replacing the aorta with a synthetic graft if the dilation 
near the aortic root advances to 50 mm in diameter. Dissections of the descending aorta 
generally do not proceed retrograde toward the carotids, and may be managed by 
reducing blood pressure and heart rate. Nevertheless, surgical repair is indicated if the 
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dissection approaches collateral vessels or further dissections occur (Pyeritz, 2000). 
With treatment, many Marfan patients have a lifespan of seventy years, which 
approaches that of the normal population (Milewicz et al., 2005). 
Fibrillin-1, Microfibrils, and Elastic Fibers 
 First identified in 1986 as the gene responsible for Marfan syndrome (Sakai et 
al., 1986), the fibrillin-1 gene (FBN-1) is located on chromosome 15. It extends over 110 
kilobases, and contains 65 exons (Kielty and Shuttleworth, 1995). The gene product, 
fibrillin-1, is a ~350 kDa glycoprotein containing 47 epithelial growth factor-like (EGF) 
and 8 TB motifs, the latter named for their homology with the latent transforming 
growth factor β binding proteins (LTBPs). The EGF and TB motifs contain six and eight 
cysteine residues, respectively, and 43 of the EGF motifs, generally noted cbEGFs, 
contain Ca2+ binding sites (Kielty et al., 2005). During the search for the FBN-1 gene, 
another fibrillin gene, FBN-2, was fortuitously discovered (Lee et al., 1991). The FBN-2 
gene product, Fibrillin-2, is nearly identical to fibrillin-1, with the exception that a 
glycine-rich region replaces a proline-rich region found near the N-terminus in fibrillin-1 
(Kielty and Shuttleworth, 1995). Although fibrillin-2 associates with fibrillin-1 in elastic 
fibers, it has a different expression pattern during development, with fibrillin-2 
production generally peaking before fibrillin-1 (Zhang et al., 1994; 1995).  
 Fibrillin-rich microfibrils, composed primarily of fibrillins 1 and 2, are elastic 
proteins found in tissues throughout the body. While fibrillin microfibrils provide the 
sole source of elasticity in invertebrate tissues, they associate with elastin in elastic 
tissues such as the lungs, skin, and vasculature in vertebrates. Microfibrils also contain 
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numerous other accessory proteins, glycoproteins, and proteoglycans, the functions of 
many of which are poorly understood. Microfibril-associated glycoprotein 1 (MAGP-1) 
is found in nearly all microfibrils, while MAGP-2, which is structurally similar, is 
located only in certain tissues. Some believe MAGP-2, a cell adhesion molecule, has cell 
signaling effects during elastinogenesis and microfibril assembly, and that MAGP-1 
plays a vital, though unknown, role in microfibrils. LTBP-1 colocalizes with microfibrils 
in embryonic skin and bone, while LTBP-2 colocalizes with microfibrils in elastic fibers. 
The proteoglycan decorin is located in the microfibrilar mantle of elastic fibers, as is the 
protein fibulin-2, generally at the microfibril-elastin interface (Kielty et al., 2002b). 
Some believe a related protein, fibulin-5, binds tropoelastin to a microfibrilar template 
during elastogenesis and connects elastic fibers and microfibrils to cell membranes 
(Ramirez et al., 2004). 
  Under rotary shadowing, isolated fibrillin microfibrils have an apparent diameter 
of ~10 nm with repeating high-mass heart-shaped structures and filamentous low-mass 
interbead regions. When untensioned, microfibrils have an average periodicity of ~56 
nm and can elastically extend approximately forty percent (Kielty et al., 2002a). Little is 
definitively known about the organization of fibrillin within microfibrils, but many have 
proposed alignment models, including a model based on antibody binding and another 
based on cbEGF domain dimensions and untensioned microfibril periodicity. One such 
model suggests that the fibrillin molecules are arranged head to tail, and that protein 
folding in the proline-rich region and at certain TB-cbEGF linkages reduce the 
periodicity to ~56 nm. Mass-averages at various locations in the microfibril are 
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consistent with predicted masses if the microfibril is eight fibrillin molecules in diameter 
(Baldock et al., 2001).  
Using molecular combing, Sherratt et al. (2003) calculated the Young’s modulus 
of isolated microfibrils using Hooke’s law. The authors justified this assumption by 
citing small-angle X-ray diffraction studies which indicated that microfibrils are linearly 
extensible in the periodicity range of 56-70 nm. As the combed length of a majority of 
the microfibrils was 70 nm, it seems reasonable to assume that the microfibrils were 
extended in their linear domain. Using two measures of microfibril diameter, 
transmission electron microscopy (TEM) and x-ray diffraction, they estimated the 
Young’s modulus to be between 78 and 96 MPa. Both values are two orders of 
magnitude larger than the Young’s modulus for single purified elastin fibers (Aaron and 
Gosline, 1981), and Sherratt et al. suggest that microfibrils act as stiff reinforcing 
filaments in elastic tissues. Interestingly, in a 1962 paper, Carton et al. found that when 
fresh isolated elastic fibers were extended, the force increased linearly until the fiber was 
extended by about 80 percent, and thereafter rose exponentially until the fiber broke at 
approximately 130 percent extension. The authors noted that the tested fibers did not 
stain for collagen, and suggest that the force-stretch behavior is intrinsic phenomenon. 
Aaron and Gosline (1981) suggest that each elastic fiber is encased in a collagen sheath, 
but given what is now known about the structure of elastic fibers, it seems reasonable to 
assume that the stiff microfibrils cause the behavior seen by Carton et al. If microfibrils 
do limit the extension of elastin, they may protect the elastin from long-term damage, 
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playing a role in tissue homeostasis as suggested in Charbonneau et al. (2004), Ramierez 
and Pereira (1999), and Arteaga-Solis et al. (2000). 
Davis et al. (2002) suggest that commonly used tissue and microfibril preparation 
methods remove microfibril accessory proteins. Using a quick-freeze technique, they 
found that the microfibrils contained three small beads between two larger beads located 
~50 nm apart, which they believe represent the beads seen in previous studies of isolated 
microfibrils such as those conducted by Kielty et al. (2002a). The large beads were 
aligned between microfibrils, with MAGP-1 staining fibers extending between the larger 
beads. Disruptive treatment of the zonules before imaging produced isolated microfibrils 
with a similar appearance to those found in previous studies, and small monomer beads 
with numerous thin fibers attached. Davis et al. believe the small beads in the interbead 
region consist of accessory proteins which were removed during preparation in previous 
studies, and that believe the separated beads represent aggregates of MAGP-1 or other 
auxiliary proteins. 
In a study of cultured pigmented epithelium (PE) cells, which produce 
microfibril networks but do not secrete elastin, Robb et al. (1999) found two populations 
of microfibrils, one coated with an unknown material and one that was uncoated. 
Although the coating material was not identified, the coated microfibrils appeared 
similar to sub-endothelial microfibrils found in the aorta, which stained strongly for 
fibronectin in previous studies (Davis, 1993; 1994). When the PE cells were transfected 
with genes coding for bovine tropoelastin, they produced a microfibril-elastin matrix 
similar to cultured controls, with the elastin preferentially located near coated 
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microfibrils. However, the elastin fibers were not surrounded by a microfibrilar sheath, 
as seen in elastic tissues, which the authors attribute to lack of an appropriate structural 
and mechanical environment (Robb et al., 1999).  
Although tropoelastin can self-assemble, or coacervate, in vitro without 
association with microfibrils (Bellingham et al., 2001), Kozel et al. (2003) argue that 
initial deposition of elastin does not involve coacervation, but instead suggest that 
microfibrils nucleate elastin aggregates. Given this theory, one would expect that a lack 
of fibrillin-1 would prevent elastogenesis. A recent study (Carta et al., 2006) found that 
mice without the fibrillin-1 gene form intact elastic fibers, although these mice usually 
died within two weeks, primarily due to aortic rupture. At death, the mice had 
disorganized elastic lamina, but normal elastin cross-linking, proving that fibrillin-1 is 
not necessary for deposition and cross-linking of elastin. Although mice without the 
fibrillin-2 gene have a normal lifespan, fibrillin-2 null mice crossed with heterozygous or 
homozygous fibrillin-1 null mice have a significantly decreased survival rate, often 
dying shortly after embryonic day 14.5. Analysis of embryonic day 14.5 double null 
mice showed decreased or delayed elastogenesis, indicating that elastin deposition 
requires fibrillin microfibrils. Carta et al. believe that fibrillin-1 controls neonatal 
maturation of the elastic lamina and structurally supports the aortic wall, while fibrillin-2 
acts as a scaffold for elastin deposition, although fibrillin-1 can compensate for a lack of 
fibrillin-2.  
 Given the large number of calcium-binding motifs in the fibrillin molecule, one 
would expect that metal ions would play a significant role in both the molecule and its 
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aggregates. In their study of cultured microfibrils, Cardy and Handford (1998) examined 
the effect of metal ions on the periodicity and flexibility of individual microfibrils. Using 
microfibrils produced by cultured fibroblasts, they found that calcium chelation by both 
EGTA and EDTA reduced the periodicity and increased the flexibility of the 
microfibrils. This effect was reversible when the microfibrils were placed in a high Ca2+ 
solution, but were not reversible in a high Mg2+ solution. Earlier studies by the same 
group on cultured normal and Marfan microfibrils demonstrated the effect of a single 
mutation in an interbead calcium-binding EGF. The researchers synthesized both a 
normal and a mutant peptide, duplicating a specific cb-EGF sequence known to cause 
Marfan syndrome. When subjected to nuclear magnetic resonance analysis, the mutant 
peptide showed a slight difference from the normal, and the difference increased 
markedly when both peptides where saturated with Ca2+. Ultrastructural studies of intact 
mutant microfibrils further illustrated the effects of the mutation, with the interbead 
region of the mutant fibrillin appearing diffuse and similar to microfibrils treated with 
EDTA, even with the application of calcium ions (Handford et al., 1995). 
Although elastin is known to have a half-life of approximately 70 years (Kielty et 
al., 2005), the half-life of fibrillin microfibrils has not been quantified. However, it is 
theorized that both elastic fibers and microfibrils have a half-life similar to that of elastin 
(Kielty and Shuttleworth, 1995). Ross and Bornstein, in their 1969 paper, showed that 
both elastin and microfibrils were generally unaffected by collagenase and 
hyaluronidase, but that microfibrils were degraded by trypsin or chymotrypsin while the 
elastin remained intact. When the elastic fibers were treated with elastase, the 
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microfibrils were initially unaffected, but partial degradation was apparent after 45 
minutes of exposure.  
In their investigation of the protective effects of Ca2+ binding against proteolysis, 
Reinhardt et al. (1997) studied whole fibrillin-1 molecules and recombinant fibrillin 
fragments. The fragments, in addition to the complete fibrillin molecule, showed much 
higher rates of degradation in the presence of EDTA than Ca2+ when exposed to several 
proteinases, including trypsin and elastase. The fragments were significantly degraded 
after one hour of incubation with each enzyme and EDTA, while incubation with the 
same enzymes and Ca2+ had very little effect. The protective effect of calcium ions was 
not complete, as the fragments were unable to withstand 23 hours of incubation. The 
digestion products indicated that removal of calcium from the individual cb-EGF motifs 
caused a structural change, rendering the fibrillin fragments (and, by extension, the 
fibrillin molecule) susceptible to proteolysis. Not all of the digestion products can be 
explained by this theory, however, and it was proposed that calcium binding stabilizes 
tandem arrays of cb-EGF motifs in an as yet unknown way.  
Mouse Models of Marfan Syndrome 
In order to study Marfan syndrome in a laboratory setting, Ramirez et al. 
developed two strains of mice that display many of the phenotypic marks of the disease, 
including aortic dissections. One strain, mg∆, produces abnormally short fibrillin-1 at 
levels significantly less than normal. The knockouts for this strain appear phenotypically 
normal at birth, but die within two weeks due to dissection of the ascending aorta 
(Ramirez and Pereira, 1999). The second strain, mgR, was discovered fortuitously 
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during the development of mg∆ and produces normal fibrillin at levels a fifth that of 
normal (Pereira et al., 1999). 
Mice homozygous for the mgR mutation have apparently normal vascular elastic 
lamina at birth, but develop obvious focal calcifications of the elastic lamina as early as 
6 weeks. At approximately 8 weeks, medial monocyte infiltratation develops, in addition 
to fragmented elastic lamina, loss of elastin, and aortic dilation. After 9 weeks, intimal 
hyperplasias appear near the calcified lesions, as well as smooth muscle cell (SMC) 
invasion and disorganized deposition of elastin and collagen. The mgR strain died at an 
average age of 3.6 months, often with signs of vascular involvement (Pereira et al., 
1999). Studies by Bunton et al. (2001) on the mgR strain found elastic lamina 
breakdown within the media while the internal and external elastic media remained 
intact. They also noted an increased synthetic phenotype among the SMCs, 
inflammatory cell infiltration, and increased MMP levels. The researchers suggested 
further that mgR mice lacked microfibrils due to decreased production of fibrillin-1, and 
that this deficiency reduced the number of connections between the smooth muscle cells 
and the elastic lamina. As the mice aged, the cumulative effect of normal blood pressure 
broke the connections further, removing the SMCs from their normal environment 
within the extracellular matrix. This loss of context caused the SMC phenotype to 
become synthetic, producing matrix components as well as MMP9, inducing early 
elastolysis as the cells attempted to return their external environment to normal. As the 
disease progressed, the external and internal lamina were disrupted, allowing 
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inflammatory cells to migrate in, which in turn caused extensive elastolysis and wall 
breakdown. 
Fibrillin and Vascular Mechanics 
Due to the devastating effects of aortic dilation and dissection, the aorta in 
Marfan syndrome has been studied extensively in an attempt to predict and treat 
progressive aortic dilation. Jeremy et al. (1994) reported that echocardiographic 
measurements of vascular mechanics, such as pulse wave velocity and aortic 
distensibility, indicated that Marfan ascending aortas were substantially stiffer than those 
of age-matched controls. Although it is well-known that that aorta stiffens with age 
(Avolio et al., 1983; 1985), this 1994 study found that the stiffness of Marfan aortas was 
greater at all ages than that of the oldest controls. The slope of the aortic-stiffness/age 
relation was also increased in the Marfan group, which the authors believe indicates an 
altered load-bearing capacity due to progressive elastin deterioration within the vessel 
wall. Using magnetic resonance imaging, Groenink et al. (2001) measured increased 
pulse wave velocities along the entire length of the aorta in Marfan patients as compared 
to healthy controls, as well as decreased distensibilities in the aortic arch and near the 
aortic bifurcation. These data indicate that the entire aorta stiffens in Marfan syndrome, 
not only the aortic root or arch.  
Using pulse wave velocity measurements, Marque et al. (2001) calculated a four-
fold increase in the elastic modulus of homozygous mgR aortas as compared to wild-
type mice. They also measured the pulse wave velocity at different pressures by 
inducing hypotension using sodium nitroprusside. The pulse wave velocity verses 
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pressure curves had similar low-pressure values for both the knockout and wild-type 
mice, but the knockout curve increased nearly twofold compared to the wild-type curve 
at normal pressures. Groenink et al. (1998) addressed the effects of pharmacological 
pressure reduction on pulse wave velocities. Application of a β-blockade increased the 
distensibility throughout the aorta, but did not produce a statistically significant 
difference in aortas of control patients. Except at the level of the aortic root, 
distensibility between the Marfan and control groups were not statistically different 
either before or after β-blockade. The pulse wave velocity did decrease significantly 
after medication in the Marfan group, and although the pulse wave velocities between 
the two groups were statistically different before the β-blockade, they were not 
afterward. The authors believe that decreasing blood pressure in Marfan patients results 
in increased compliance because mechanical behavior of the vessels is dominated by 
collagen, which has an exponential stress-strain response function. Thus, a blood 
pressure decrease in Marfan patients would have a greater effect on distensibility than in 
control patients, whose aortas have a more linear stress-strain response due to the 
presence of intact elastic lamina in the media.  
Although mutated fibrillin has a dramatic effect on vascular mechanics, several 
studies have linked normal fibrillin-1 genotypes to altered pulse pressure, an indirect 
measure of vascular stiffness. Briefly, the differences between fibrillin-1 genotypes are 
based on analysis of a non-coding region, intron 28, within the fibrillin gene containing a 
variable number of tandem repeats, and thus a different length in basepairs. Although 
four different repeat lengths have been identified within intron 28, only three of the 
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sixteen possible pairings are commonly found in both healthy patients and those with 
abdominal aortic aneurysm (AAA) or coronary artery disease (CAD). Powell et al. 
(1997) suggested that in healthy patients, the three genotypes, 2-2, 2-3, and 2-4, strongly 
correlate to differences in pulse pressure, with less strong correlations to differences in 
mean pulse pressure and mean systolic pressure. Specifically, the 2-3 group had higher 
pulse pressures, the 2-4 group had lower pulse pressures, and the 2-2 group had pulse 
pressures around the median. These findings confirmed a previous study of patients with 
AAAs. In addition, the previous study found that patients with the 2-3 geneotype were 
more likely to have popliteal aneurysms in addition to the AAA, while the 2-4 group did 
not have popliteal aneurysms. Both groups with and without popliteal aneurysms had 
similar incidences of the 2-2 genotype and rarer genotypes (MacSweeney et al., 1996). A 
study of patients with coronary artery disease (CAD) found that the 2-3 genotype 
correlated strongly to an increased vascular impedance and the severity of the disease, 
measured in terms of repeat angioplasties and a maximum occlusion of more than 90 
percent. In addition, 14 percent of the CAD patients had a rare genotype compared to 5 
percent found in the healthy population of the 1997 study (Medley et al., 2002). A recent 
study by Powell et al. (2005) correlated to an increase in aortic stiffness, mean arterial 
pressure, and pressure strain elastic modulus in healthy, middle-aged patients with the 2-
3 geneotype. These findings suggest that even differences in normal fibrillin-1 play a 
role in the mechanics of the vasculature, possibly by subtly altering the arterial wall 
structure.  
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In summary, mice homozygous for the mgR mutation have abnormalities in their 
vasculature and serve as a disease model for the human disease of Marfan syndrome.  It 
is thus constructive to study these mice to provide clinicians with data to effectively treat 
Marfan patients. However, the similarity of the Marfan vasculature to that of the 
vasculature in advanced age expands the impact of Marfan studies to the general 
population. In addition, fibrillin-1 is thought to present the growth factor TGF-β to cells, 
making mgR mice applicable to the study of cell signaling in development and maturity. 
It is by studying both the mechanics and biological response that we can begin to model 
the vasculature in both health and disease, allowing clinicians to appropriately predict 
and treat issues that arise in diseases such as Marfan syndrome, as well as problems 




 In order to further understanding of the Marfan vasculature, we wish to study the 
properties of carotids from a mouse model of Marfan syndrome. To this end, the specific 
goals of this project are: 
(1)     To quantify the response of wild-type and heterozygous mgR mouse 
carotid arteries to applied loads considering: 
(a) Responses with (active) and without (passive) SMC basal tone, 
(b) Axial and circumferential directions. 
(2)    To evaluate differences between wild-type and heterozygous arteries. 
(3)    To compare the wild-type and heterozygous responses to available data 
for mice heterozygous for elastin and mouse models of muscular 
dystrophy. 
(4)    To determine the utility of heterozygous carotids as a model of the 
Marfan vasculature. 
 This following sections describe the experimental set-up, relate the results of the 
experimental procedures, and examine the findings in a physical and historical context.  
Materials and Methods 
Artery Isolation and Setup in Computer Controlled Testing Device 
Breeding pairs of mgR+/- mice were given by Dr. Francesco Ramirez 
(University of Medicine and Dentistry of New Jersey), and their offspring used for 
experiments. All animals were maintained by the Texas A&M University Comparative 
Medicine Program (CMP) and were used in accordance with the University Laboratory 
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Animal Care Committee (ULACC) guidelines. MgR+/- (n = 6) male C57BL/6J-129Sv 
mice and their wild-type male littermates (n = 6), between 8 and 14 weeks old, were 
euthanized with a lethal injection of sodium pentobarbital (~50mg/kg IP) and the left and 
right common carotid arteries were isolated. One artery, generally the left, was placed in 
warm advanced Dulbecco’s modified Eagle’s medium (ADMEM, Invitrogen, Inc.), 
supplemented with 2% heat-inactivated fetal bovine serum (HI-FBS, Atlas Biologicals), 
10 mL 200 mM L-glutamine, as well as 1000 units/L penicillin and 1000 g/L 
streptomycin (P/S, Invitrogen, Inc.), and mounted on glass perfusion cannulae at both 
extremities using 6-0 suture. 
The cannulated arteries were placed in a bath of fresh, warm ADMEM 
supplemented as above within the incubator chamber of the testing device. Flow was 
initiated adventitially from reservoirs of supplemented ADMEM and a load cell was 
attached to the distal cannula. Once an image was obtained, measurements in the 
unloaded configuration (with mean pressure P = 0 mmHg and axial load f = 0 g) were 
measured. The unloaded diameter D was noted and unloaded axial length where the 
vessel just begins to bend was measured as described by Gleason et al. (2004a). After 
recording the unloaded length, the vessel was stretched to an axial stretch (λz) of 1.5, 
pressurized to 80 mmHg, and intraluminal flow was initiated (Q = 0.5 ml/min). This 
condition was maintained for approximately fifteen minutes, until all bubbles exited the 
tubing. After this equilibration period, intraluminal flow was stopped and the vessel was 
preconditioned for two cycles by axially stretching the vessel to 1.8 and cycling the 
pressure from 0 to 160 mmHg. After preconditioning, the unloaded length and diameter 
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were measured and recorded again, and the inner and outer diameters were measured by 
manually adjusting video-calipers in the following configurations: P = 0 mmHg and λz = 
1.2, 1.4, 1.6, and 1.8; P = 40 mmHg and λz = 1.4, 1.6, and 1.8; P = 80 mmHg and λz = 
1.6 and 1.8; and P = 100 mmHg and λz = 1.8.   
Mechanical and Functional Testing 
 Mechanical testing consisted of two parts, pressure diameter (P-D) and force-
stretch (f-λz) tests. During the P-D test, the vessel was axially stretched to 1.65, 1.75, and 
1.85 and held at that stretch while P cycled from 0 to 160 mmHg twice, resulting in one 
preconditioning curve and one curve used as experimental data per stretch. Similarly, 
during the f-λz tests, the pressure was maintained at 0, 60, 100, and 160 mmHg while λz 
was decreased until the vessel bent. For each pressure, the vessel was then stretched until 
the axial force exceeded 0.9 g and then returned to an unloaded length twice.  
 After mechanical testing, the vessel was stretched to λz = 1.65 and pressurized to 
P = 80 mmHg for fifteen minutes to equilibrate for the function test. At the end of this 
period, the adventitial flow was stopped and 150 µL of 10-3 M phenylephrine (PE), 
which tests the contractile ability of smooth muscle cells, was added to the ~15 mL bath 
for a final concentration of ~10-5. After fifteen minutes, 150 µL of 10-3 M 
carbamylcholine chloride (CCh), which tests the endothelium-dependent smooth muscle 
cell relaxation, was added. After fifteen minutes later, 150 µL of 10-2 M sodium 
nitroprusside (SNP), which induces endothelium-independent smooth muscle cell 
relaxation, was added, and the vessel was allowed to equilibrate for fifteen minutes.  
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 After functional testing, three vessels from each group were mechanically tested 
under passive conditions. The bath was emptied, rinsed twice with warm Hank’s 
Balanced Salt Soultion (HBSS, Invitrogen, Inc.) without calcium or magnesium, and 
refilled with warm calcium-free HBSS to which 150 µL of 10-2 SNP was added. The 
vessel was allowed to equilibrate at P = 80 mmHg and λz = 1.65 for ten minutes, and 
then the vessel was mechanically tested as described above.  
Post Processing 
 The passively tested vessels were unloaded, removed from the device, and fixed 
in 4% paraformaldehyde for one hour. Afterwards, the arteries were immersed in a 
cryoprotectant (30% sucrose) overnight. The vessels were then mounted in OCT 
medium (Tissue Tek) in isopentane cooled with liquid nitrogen, and stored at -80oC for 
future sectioning and immunohistochemical analysis. The untested carotids from each 
mouse and the non-passively tested vessels were flash frozen in liquid nitrogen and 
stored at -80oC for future isolation and analysis of RNA and protein. 
Data Processing 
 Functional vessels were selected for analysis as quantified by at least 30 percent 
contraction in response to PE (as compared to the final diameter of the vessel fifteen 
minutes after application of SNP) and at least 10 percent dilation (from the contraction 
caused by PE) in response to CCh. Axial force, axial stretch, pressure, and outer 
diameter data were collected for each vessel at 4 Hz during all tests. The inner and outer 
diameters measured allowed us to calculate the volume of the vessel wall using 
  ( )22 ablV += π   (1) 
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where l is the length, a is the inner radius, and b is the outer radius in the current 
configuration. The four different volume values found at P = 0 mmHg were averaged to 
give V . The remaining six volume calculations were used to test the accuracy of the 
calculated inner radius based on the volume estimate. Assuming incompressibility, the 
mean volume and outer diameter values allowed the luminal radius a and the wall 
thickness h to be computed at all states using the following formulae: 
  ( )2a b V lπ= − , (2) 
and 
  ( )h b a= − . (3) 
This, in turn, allowed us to calculate the mean axial and circumferential Cauchy stresses 
(σz and σθ, respectively) at every test point using 
  ( )2 2z
f
b a




σ = . (5) 
The axial stretch ratio was calculated via 
  z l Lλ =  (6) 
where L is the unloaded length, whereas the circumferential stretch ratio was calculated 
using the inner radii 
  a Aθλ =  (7) 
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where A is the inner radius calculated using the unloaded length and unloaded outer 
radius. The inner and outer radii, wall thickness, axial and circumferential stresses and 
stretches can thus be calculated at every test-point using the unloaded configuration 
measured prior to testing. After interpolating between test-points, the loaded dimensions, 
axial force, and axial and circumferential stresses were analyzed with SPSS software 
using one-factor analysis of variance (ANOVA) for p<0.05. The body weights and ages 
of the mice, as well as the mean wall volumes and unloaded arterial dimensions were 
similarly analyzed for p<0.05. For the P-D test, the outer diameter and axial force were 
compared between pressures of 2 and 160 mmHg, and the circumferential stress was 
compared for circumferential stretches between 0.28 and 3.8 (these ranges of 
independent variables were common for all vessels of the two genotypes, thus enabling 
statistical comparison). For the f- λz test, axial force and axial stress were compared for 
axial stretches between 0.5 and 2.5. 
 Another comparison from the f- λz test was made. It is known that blood vessels 
are extended far beyond their unloaded length in vivo, and that at the in vivo axial stretch 
(λz in vivo, the in vivo length normalized by the unloaded length), the axial force tends to 
remain constant over a range of pressures (Humphrey, 2002). One way to discern the in 
vivo axial stretch of arteries already isolated from animals is to examine the results of the 
force-stretch curves and find the point where the force is the same for different pressures 
(in this case, pressures of 60, 100, and 160 mmHg). The axial stretch corresponding to 
this common axial force represents the in vivo axial stretch, where the axial force 
remains relatively constant as the pressure is cycled. The intersection points of the 60, 
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100, and 160 mmHg force-stretch curves were found for each artery (by interpolating 
between the two closest axial stretch points) and the three intersection points were 
averaged to yield an estimate for that vessel’s in vivo axial stretch. The λz in vivo values 
were compared using ANOVA for p<0.05.  
 The outer diameters measured in response to the various agonists during the 
function test were normalized to the final diameter in the presence of SNP and compared 
using ANOVA for p<0.05.  
Results 
Mouse Characteristics and Functional Response 
 The mean mouse characteristics and vessel properties are shown in table 1. With 
the exception of the unloaded outer diameter, OD, no values were significantly different 
between the wild-type and heterozygous groups. Basal tone, contraction to PE, and 
dilation to CCh are normalized to the final diameter after fifteen minutes in the presence 
of SNP. Wild-type and heterozygous groups had an average basal tone of 97 and 94 
percent, respectively, but in the vessels passively tested, the vessels dilated further, 
resulting in a average basal tone of approximately 90 percent of the final diameter in 
HBSS without Ca2+. Representative function curves can be seen in figure 1. The wild-
type mouse was tested on 6/16/06 and had a basal tone of approximately one percent, 
while the heterozygous mouse was tested on 6/23/06 and had a basal tone of 
approximately 10 percent. When compared to previous studies on different strains 
(C57BL/6 and FVB/N), the endothelial dilation was quicker and not as long-lasting, with 
the vessel dilating to its maximum CCh diameter within three minutes and then 
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decreasing to a level slightly above its minimum diameter in the presence of PE alone. 
C57BL/6 vessels reached their maximum diameter shortly before SNP was added, and 
FVB/N vessels reached their maximum diameter at about ten minutes and then 
decreased to a level below the minimal diameter in the presence of PE alone (Dye, 2005; 
Gleason et al., 2004a). 
Mechanical Response—Pressure Diameter Tests 
 The general mechanical response of both groups of mouse carotid arteries to 
biaxial testing was similar to that reported for other mouse carotids tested in our lab 
(Dye, 2005; Gleason et al., 2004a) and elsewhere (Wagenseil et al., 2005). During the 
pressure-diameter tests, as the pressure increased, the vessel was initially rather 
compliant, with the diameter increasing rapidly. However, at near-physiological 
pressures (80-100 mmHg) the vessel became less compliant and the diameter increased 
only slightly. Figures 2 and 3 show the averaged wild-type and heterozygous pressure-
diameter curves, with basal tone and in the passive state, respectively. The curves 
separate move downward (i.e. become less complaint) as the axial stretch increases, 
especially at higher pressures. Although the active wild-type PD curves were not 
generally significantly different when compared to active heterozygous curves, the 
differences between the active PD curves at λz = 1.65 did reach statistical significance at 
some sub-physiological pressures, namely 2-6, 28, 32-60, 64-66, and 70-72 mmHg. One 
point, 4 mmHg, was statistically different in the active PD curves at λz = 1.75. The 
passive PD curves did not show a statistical difference when the wild-type and 
heterozygous data were compared, possibly due to low sample sizes.  
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Table 1 
Comparisons of mouse and vessel properties for 
wild-type and heterozygous mgR mice.  
  Wild-Type Heterozygous 
  Animal Properties 
Body 
Weight (g) 21.800 ± 1.479 23.283 ± 1.902 
Age (wks) 11.235 ± 1.876 11.305 ± 1.060 
  Vessel Properties 
V (mm3) 0.187 ± 0.021 0.193 ± 0.040 
λz in vivo 1.706 ± 0.077 1.704 ± 0.062 
f at λz in vivo 
(mN) 3.301 ± 0.693 3.200 ± 0.558 
  Unloaded Dimensions 
L (mm) 3.093 ± 0.372 3.542 ± 0.815 
OD (µm) 363 ± 21 342 ± 17* 
A (µm) 116 ± 15 108 ± 13 
H (µm) 65.0 ± 4.5 63.0 ± 5.5 
  Functional Response 
Basal        
Tone 0.972 ± 0.027 0.940 ± 0.057 
Contraction 
to PE 0.637 ± 0.046 0.669 ± 0.025 
Dilation to 
CCh 0.783 ± 0.064 0.820 ± 0.023 
OD with 
SNP (µm) 541 ± 26 532 ± 14 
All data are represented as mean ± standard 
deviation. A * indicates statistical significance 




Fig. 1. Representative functional response curves. PE was added at 15 minutes, CCh at 
30 minutes, and SNP at 45 minutes.  
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Figures 4 and 5 show representative active and passive circumferential stress-
strain curves. The wild-type vessel was tested on 6/14/06 and the heterozygous vessel 
was tested on 7/24/06; these data were chosen because their in vivo stretches (as 
calculated from the force-stretch tests under basal tone) are similar to the average in vivo 
stretches with basal tone. Overall, the wild-type and heterozygous circumferential stress-
strain values were not significantly different, either with or without basal tone. The 
active heterozygous curves seem to increase in variability as the axial stretch increases, 
and the curves shown are similar to the majority of data collected. The passive 
heterozygous curves shown grow closer to the mean as the axial stretch increases, and 
represent the left-most curves of the set. Both the active and passive wild-type data seem 
to decrease in variability as the axial stretch increases, and the wild-type data curves 
shown are to the right of the mean. No statistically significant difference was found 
between either the active wild-type and heterozygous curves or the passive wild-type 
and heterozygous curves. In both active and passive tests for both groups, the vessels 
exhibit stress stiffening as the axial stretch increases, moving to the left on the 
circumferential stretch axis. 
Because the axial force remains constant over a range of pressures at the in vivo 
axial stretch (Humphrey, 2002), force-pressure curves can confirm the in vivo stretches 
calculated from the force-stretch tests. Figures 6 and 7 show the averaged active and 
passive force-pressure curves, respectively. In both figures, the force decreases at an 
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Fig. 2. Averaged active wild-type and heterozygous pressure-diameter curves. Wild-type 
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Fig. 3. Averaged passive wild-type and heterozygous pressure-diameter curves. Wild-
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Fig. 4. Representative active wild-type and heterozygous circumferential stress-strain 
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Fig. 5. Representative passive wild-type and heterozygous circumferential stress-strain 
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Fig. 6. Averaged active wild-type and heterozygous force-pressure curves. Wild-type 
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Fig. 7. Averaged passive wild-type and heterozygous force-pressure curves. Wild-type 
curves are denoted by solid symbols, heterozygous curves by hollow symbols.  
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axial stretch lies somewhere between 1.65 and 1.75. No statistical difference between the 
wild-type and heterozygous curves was found, either in the active or passive case. 
Mechanical Response—Load-Stretch Tests 
Figures 8 and 9 show the intersections of representative active wild-type and 
heterozygous force-stretch curves, respectively. The wild-type vessel was tested on 
6/14/06 and the heterozygous vessel was tested on 7/24/06. The 60, 100, and 160 mmHg 
curves in both the wild-type and heterozygous vessel intersect at an axial stretch of 
approximately 1.70, with an axial force of 3 and 3.5 mN, respectively. Passive curves are 
similar, and are shown with their active counterparts in Appendix A. Figures 10 and 11 
show the axial stress-stretch curves for the representative active wild-type and 
heterozygous vessels. The maximum axial stress is less than the maximum 
circumferential stress shown in Figures 4 and 5. In both the axial force-stretch and axial 
stress-stretch graphs, the x-intercepts of the curves move to the right and the slope 
increases as the pressure increases. Overall, the wild-type axial force-stretch and axial 
stress-stretch values were not significantly different from the heterozygous values.  
 Figure 12 and table 2 show the averaged in vivo stretches and forces for wild-
type and heterozygous vessels in both the active and passive state. No statistically 
significant difference was found between the active wild-type and heterozygous data or 
between the passive wild-type and heterozygous data. Although the in vivo stretch 
decreased slightly under passive conditions, the change was not significant when the 
active and passive groups were compared by genotype. Similarly, the passive in vivo 
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Fig. 11. Representative active heterozygous axial stress-stretch curves. 
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Fig. 12. Averaged active and passive axial in vivo stretches and forces.  
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Table 2 
Comparisons of active and passive in vivo stretches and forces for wild-type 
and heterozygous mgR mice. 
Active Passive 
 
Wild-Type Heterozygous Wild-Type Heterozygous
λz in vivo 1.706 ± 0.077 1.704 ± 0.062 1.645 ± 0.040 1.694 ± 0.067
f at λz in vivo 
(mN) 3.301 ± 0.693 3.200 ± 0.558 3.072 ± 0.707 3.762 ± 0.488




 Given that mice heterozygous for the mgR construct are not phenotypically 
different from wild-type controls (Pereira et al., 1999), it was not surprising that the 
majority of the pressure-diameter, force-pressure, circumferential stress-stretch, axial 
force-stretch, and axial stress-stretch data were not significantly different in either in the 
passive state or with basal tone. Nevertheless, several non-statistically significant trends 
can be seen in the pressure-diameter test data. Specifically, the heterozygous data tend to 
have smaller diameters than the wild-type curves at physiological pressures and the 
heterozygous circumferential stress strain curves tend to be shifted to the left of the wild-
type curves. Thus, the heterozygous vessels seem slightly less compliant than their wild-
type counterparts. No similar trends could be seen in the passive data or the axial force-
stretch data, which when combined with the slightly larger average basal tone might 
suggest that the smooth muscle cells are slightly more active in the heterozygous vessels. 
However, the passive sample size is small, and no trends are observed in the 
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heterozygous basal tone, making such a suggestion difficult to establish at this time. 
Further collection of passive data may clarify this question. 
While acute mechanical studies can prove useful for determining tissue 
properties, it is also important to study how those properties change over time. This is 
generally accomplished with culture experiments, either in or ex vivo. Although in vivo 
culture studies are fairly simple to perform and can usually be carried out long term, ex 
vivo studies offer superior control, albeit in a setting foreign to the tissue. Our lab group 
has developed a sophisticated computer controlled vessel culture system capable of 
controlling both the internal pressurization, axial stretch, and luminal flow (Gleason et 
al., 2004a). Vessels can thus be studied under different conditions to see how they adapt, 
offering clues to their internal makeup and unique mechanical properties. However, 
these ex vivo culture studies may fail due to contamination. Appendix C describes 
several cleaning protocols used in the lab to combat contamination, decreasing the time 
and effort necessary to collect data. Future work on Marfan model mice in this lab will 
undoubtedly involve culture tests to deduce the effects of hypertension on the mechanics 
and biology of the Marfan vasculature.  
Because heterozygous mgR mice have not been extensively studied, the results 
of surgical or pharmacological intervention are currently unknown. Surgical procedures 
such as aortic banding or carotid ligation may cause Marfan-like lesions to develop, as 
might drug-induced hypertension. Further, all the mice tested in this study, although 
mature adults, were fairly young, and mice heterozygous for mgR have not been studied 
in advanced age, and thus the time-course of their aging process is currently unknown. It 
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may be that as the mgR vasculature ages, it may be more prone to Marfan symptoms, in 
addition to the typical stiffening and elastic fiber calcification that occur with age 
(Avolio et al., 1983; Bunton et al., 2001).  
While the two groups studied were not significantly different, they proved 
qualitatively different from mice studied previously. Wendy Dye quantified the 
biomechanical responses of two models of muscular dystrophy and compared them to a 
wild-type control (C57) in her 2005 thesis. The two models, mdx and sgcd, lack portions 
of the dystrophin-glycoprotein complex, which connects the cytoskeleton to the 
extracellular matrix through a number of transmembrane and intracellular proteins and 
glycoproteins. She found that both the mdx and sgcd strains generally exhibited stiffer 
behavior in the axial and circumferential directions than wild-types and that the 
knockouts had a decreased in vivo stretch when compared to controls. Although the 
mechanical data found by Dye were qualitatively different than the data analyzed in this 
thesis, the functional response and vessel properties were different as well. These 
findings may be expected when taken in light of a recent paper discussing the effect of 
mouse strain on vascular remodeling (Harmon et al., 2000). The researchers ligated the 
left common carotid in eleven in-bred mouse strains, allowed the vasculature to remodel, 
and then removed the left and right common carotids for morphometric analysis. They 
found that the strains, which included C57BL/6J and 129/SvJ, varied in their formation 
of neo-intimal lesions, medial hypertrophy, and their ability to reduce their lumen 
diameter in response to decreased flow. This paper, together with the data collected by 
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Dye, suggest that the hybrid background of the animals in this study results in vessels 
with unique physical and biomechanical properties.  
 One such important property is the in vivo axial stretch. It is known that blood 
vessels are extended far beyond their unloaded length in vivo, and that at the in vivo axial 
stretch the axial force tends to remain constant over a range of pressures (Humphrey, 
2002). Previous studies have estimated the in vivo stretches for wild-type FVB/N, wild-
type C57, and the two models of muscular dystrophy mentioned above (Gleason et al., 
2006; Dye, 2005). These values ranged from approximately 1.87 and 1.88 for the FVB/N 
and C57 groups, respectively, to 1.74 and 1.78 for the mdx and sgcd muscular dystrophy 
models. The value found in this study for both the heterozygous mgR and wild-type 
mice was 1.70, substantially lower than both the controls and disease models studied 
previously. Presumably this difference in the in vivo stretches is due to physical and 
physiological differences between strains.  
Given elastin composes approximately 20 percent (dry weight) of the carotid 
artery (Gleason et al., 2004b), it is reasonable to assume that elastin plays an important 
role in vascular biomechanics. Mice heterozygous for the elastin gene have 30 percent 
less elastin content in the vasculature, as compared to wild-types (C57BL/6J), as well as 
an increased number of thinner elastic lamina and hypertension (Wagenseil et al., 2005). 
Wagenseil et al. performed inflation and extension tests on several major vessels (the 
ascending aorta, abdominal aorta, and common carotid) from both wild-type and elastin-
deficient mice and found that the elastin-deficient vessels were less compliant, had 
smaller diameters, and smaller in vivo stretches than wild-types.  The in vivo stretch the 
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elastin-deficient carotids was approximately 1.3, although the wild-type in vivo stretch 
was approximately 1.45, significantly smaller than that found in our lab, perhaps due to 
differences in experimental procedure or in vivo stretch calculation.  
Fibulin-5 interacts with elastic fibers and links them to the cells via integrins 
(Kelleher et al., 2004). Fibulin-5 is also necessary to tropoelastin deposition and elastic 
fiber development (Robinson et al., 2006; Kielty et al., 2005). Fibulin-5 deficient mice 
have disrupted elastin formation, resulting in vascular malformations and narrowing of 
the proximal aorta (Ramirez et al., 2004). In a study similar to those listed above, Dr. 
Rudolph Gleason found that carotids from fibulin-5 knockout mice have biomechanical 
properties similar to those of elastin-deficient vessels. The fibulin-1 null vessels were 
significantly stiffer than wild-type vessels, and had an in vivo stretch of approximately 
1.45 verses 1.85 in the wild-type (Gleason, unpublished observations). 
In order to model and predict mechanical behavior, the vasculature is often 
simplified to a bare minimum (Gleason and Humphrey 2004; 2005), but a biological 
tissue is composed of far more than three or four components, and these components 
interact with each other in unknown ways. Although the models provide an important 
first approximation, the subtle interactions between components can only be studied in 
actual tissues. Studies such as those listed above show a spectrum of phenotypes from 
diseased to healthy, giving clues about how the vasculature adapts to missing or 
decreased levels load-bearing proteins such as elastin and fibrillin-1 or proteins which 
connect cells to the matrix such as dystrophin, sarcoglycan delta, and fibulin-5. These 
studies demonstrate how cells alter their environment in response to altered mechanical 
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loads. It is by studying both the mechanics and biological response that we can begin to 
model the vasculature in both health and disease, allowing clinicians to appropriately 
predict and treat issues that arise in diseases such as muscular dystrophy and Marfan 





CONCLUSION AND RECOMMENDATIONS 
 This study successfully quantified the active and passive biomechanical 
responses of both wild-type and heterozygous mgR mouse carotid arteries to inflation 
and axial stretching tests. Although the two groups did not prove statistically different, 
they were qualitatively different from other mice studied in our lab and elsewhere. In 
addition, this study proved conclusively that the heterozygous mgR group is not suitable 
as a model for Marfan syndrome. However, future protein and RNA analysis, in addition 
to histological staining, may demonstrate differences that can be exploited through 
surgical or pharmacological intervention to determine further the effects of graded 
fibrillin-1 deficiencies.  
 Future studies should include acute tests on mice homozygous for mgR, as well 
as two-day normotensive culture tests for wild-type and knockout groups to determine 
the biomechanical properties of mice with a Marfan phenotype. Further, the culture 
studies should be repeated at hypertensive pressure to reveal the response of both the 
wild-type and knockout groups to hypertension. Protein and RNA analysis of the acute 
knockout, cultured wild-type, and cultured knockout groups, especially regarding the 
regulation of TGF-β, may also provide clinically relevant data on the physiological 
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Fig. 13. Averaged pressure-diameter curves at an axial stretch of 1.65. Wild-type curves 























Fig. 14. Averaged pressure-diameter curves at an axial stretch of 1.75. Wild-type curves 























Fig. 15. Averaged pressure-diameter curves at an axial stretch of 1.85. Wild-type curves 


























Active Passive  
Fig. 16. Representative circumferential stress-stretch curves at an axial stretch of 1.65. 




























Fig. 17. Representative circumferential stress-stretch curves at an axial stretch of 1.75. 




























Fig. 18. Representative circumferential stress-stretch curves at an axial stretch of 1.85. 



























Fig. 19. Representative axial force-stretch curves at a pressure of 0 mmHg. Wild-type 



























Fig. 20. Representative axial force-stretch curves at a pressure of 60 mmHg. Wild-type 



























Fig. 21. Representative axial force-stretch curves at a pressure of 100 mmHg. Wild-type 



























Fig. 22. Representative axial force-stretch curves at a pressure of 160 mmHg. Wild-type 
























Fig. 23. Representative axial stress-stretch curves at a pressure of 0 mmHg. Wild-type 
























Fig. 24. Representative axial stress-stretch curves at a pressure of 60 mmHg. Wild-type 
























Fig. 25. Representative axial stress-stretch curves at a pressure of 100 mmHg. Wild-type 
























Fig. 26. Representative axial stress-stretch curves at a pressure of 160 mmHg. Wild-type 







This visual basic macro code interpolates between unevenly spaced data points. 
In this case, the program interpolates the diameter and force from collected pressure-
diameter test data for a specified table of pressure values 
 
Creates pressure "lookup table" 
    Range("J1500").Select 
    ActiveCell.FormulaR1C1 = "1" 
    Range("J1500").Select 
    Selection.AutoFill Destination:=Range("J1500:J1589"), Type:=xlFillDefault 
    Range("K1500").Select 
    ActiveCell.FormulaR1C1 = "2" 
    Range("K1501").Select 
    ActiveCell.FormulaR1C1 = "4" 
    Range("K1500:K1501").Select 
    Selection.AutoFill Destination:=Range("K1500:K1579"), Type:=xlFillDefault 
 
Does the interpolation  
    Columns("J:S").Select 
    Selection.Sort Key1:=Range("K1"), Order1:=xlAscending, Header:=xlGuess, _ 
        OrderCustom:=1, MatchCase:=False, Orientation:=xlTopToBottom 
    Range("M2").Select 
    ActiveCell.FormulaR1C1 = "=((R[1]C[-1]-R[-1]C[-1])/(R[1]C11-R[-
1]C11)*RC11+(R[1]C[-1]-(R[1]C[-1]-R[-1]C[-1])/(R[1]C11-R[-1]C11)*R[1]C11))" 
    Range("M2").Select 
    Selection.AutoFill Destination:=Range("M2:M1500"), Type:=xlFillDefault 
    Range("P2").Select 
    ActiveCell.FormulaR1C1 = "=((R[1]C[-1]-R[-1]C[-1])/(R[1]C11-R[-
1]C11)*RC11+(R[1]C[-1]-(R[1]C[-1]-R[-1]C[-1])/(R[1]C11-R[-1]C11)*R[1]C11))" 
    Range("P2").Select 
    Selection.AutoFill Destination:=Range("P2:P1500"), Type:=xlFillDefault 
    Columns("M:M").Select 
    Selection.Copy 
    Columns("N:N").Select 
    Selection.PasteSpecial Paste:=xlValues, Operation:=xlNone, SkipBlanks:= _ 
        False, Transpose:=False 
    Columns("P:P").Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Columns("Q:Q").Select 
    Selection.PasteSpecial Paste:=xlValues, Operation:=xlNone, SkipBlanks:= _ 
        False, Transpose:=False 
    Columns("S:S").Select 
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    Selection.Insert Shift:=xlToRight 
    Selection.Insert Shift:=xlToRight 
    Range("S2").Select 
    ActiveCell.FormulaR1C1 = "=((R[1]C[-1]-R[-1]C[-1])/(R[1]C11-R[-
1]C11)*RC11+(R[1]C[-1]-(R[1]C[-1]-R[-1]C[-1])/(R[1]C11-R[-1]C11)*R[1]C11))" 
    Range("S2").Select 
    Selection.AutoFill Destination:=Range("S2:S1500"), Type:=xlFillDefault 
    Columns("S:S").Select 
    Application.CutCopyMode = False 
    Selection.Copy 
    Columns("T:T").Select 
    Selection.PasteSpecial Paste:=xlValues, Operation:=xlNone, SkipBlanks:= _ 
        False, Transpose:=False 
    Columns("J:U").Select 
    Application.CutCopyMode = False 
    Selection.Sort Key1:=Range("J1"), Order1:=xlAscending, Header:=xlGuess, _ 
        OrderCustom:=1, MatchCase:=False, Orientation:=xlTopToBottom 
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APPENDIX C 





• Fill pressure transducers with 70% ethanol and cover with foil during storage. 




• Autoclave small-caliber tubing for 1 hour, 15 minutes. Larger caliber tubing may 
be autoclaved for the same amount of time. 
• Rinse pressure transducers with 70% ethanol twice in the laminar flow hood 




• Remove luminal loop first. Remove pressure transducers (unscrewing connector 
for device 1, P1), remove all remaining PTFE tape, rinse the transducer wells 
with soap until no more media is seen, and then fill with Alconox until 
everything else is cleaned. Do not allow electrical connections to get wet. 
• Remove filters and attached tubing from reservoirs. Dispose of all clogged filters 
and check tubing for media deposits. Clean tubing if necessary. 
• Rinse interior of all media-contacting tubing with hot water for 10 seconds. Drain 
and rinse with distilled water for 10 seconds. Drain tubing and allow to dry 
before autoclaving.  
• Squirt Alconox into all openings of reservoirs. Rinse thoroughly with hot water, 
then with distilled water. Repeat for stoppers. 
• Rinse pressure transducers briefly with hot water. Squirt distilled water into 
pressure transducer until the water is no longer has soapy bubbles. Tap to release 
trapped bubbles and ensure thorough rinsing. Rinse twice with 70% ethanol, 
tapping to release bubbles, and store as described above. 
 
 
Cleaning to Remove Bacteria 
• Clean as above, except squirt soap into all tubing that contacts media. Rinse 
thoroughly with hot water to remove soap. 
• If film forms in the reservoir, remove with brush and soap. 
• If contamination returns, despite cleaning tubing with soap, dispose of tubing and 
fittings and replace with fresh materials. 
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Cleaning to Remove Fungus/Mold 
• Do not leave the loops up longer than six weeks. 
• Remove clumps of fungus in reservoir with brush and soap. Pay careful attention 
to spouts. 
• Permanent staining of tubing interior and fittings is probable. Some loops may be 
rescued by cleaning as for bacterial contamination. However, it is often less 
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